Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicountry, Multicentre, Noninterventional, Retrospective Study to Describe the Real-world Management Outcomes in Patients With Unresectable Hepatocellular Carcinoma

NCT05239507 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05239507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05239507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicountry, Multicentre, Noninterventional, Retrospective Study to Describe the Real-world Management Outcomes in Patients With Unresectable Hepatocellular Carcinoma
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 1, 2022
Completion date
March 12, 2023
Enrollment
1,127 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma